Counterfeit pharmaceuticals pose a significant threat to both patient safety and the reputation of legitimate pharmaceutical companies. With counterfeit drugs infiltrating global supply chains, the risks for businesses extend beyond lost revenue—lives are at stake. Protecting your brand from counterfeit drugs is critical, as substandard or fake medications can lead to treatment failures, harmful side effects, and even fatalities. Here are five key warning signs that your pharmaceutical products may be targeted by counterfeiters and steps you can take to protect your brand and customers.

1. Unusually Low-Priced Versions of Your Drug

One of the most obvious warning signs of counterfeit pharmaceuticals is seeing your product sold at prices far below the market rate. Counterfeiters typically attract buyers with significant discounts, especially in online pharmacies or unregulated markets. When you notice abnormally low prices for your product, it’s a red flag that counterfeit versions may be circulating, leading to both financial loss and harm to patients.

How to Protect Your Brand: Conduct regular monitoring of online pharmacies and unauthorized sellers. Set up automatic price alerts that flag when your drugs are being offered at suspiciously low prices, and work with regulatory bodies to shut down illegal distributors.

2. Reports of Ineffective Medication

If you start receiving reports from healthcare providers, pharmacists, or patients about the ineffectiveness of your drug or unexpected adverse effects, this could be an indicator that counterfeit versions of your pharmaceutical are on the market. Counterfeit drugs often contain incorrect dosages, harmful additives, or no active ingredients at all, leading to treatment failures and health complications.

How to Protect Your Brand: Create a robust adverse event monitoring system that tracks patient complaints and reports from healthcare professionals. Encourage patients and providers to report issues directly to your company and investigate any recurring patterns.

3. Inconsistent or Poor-Quality Packaging

Pharmaceutical packaging is often the first line of defense in identifying counterfeit products. Counterfeiters frequently use low-quality packaging to cut costs, and their imitations often feature tell-tale signs such as spelling mistakes, faded labels, mismatched fonts, or improper seals. If your company starts receiving reports of poorly packaged products, it’s a strong indication that counterfeit versions may be in circulation.

How to Protect Your Brand: Conduct periodic in-field tests by purchasing your own products from various markets and testing the packaging for authenticity. For quicker results, leverage advanced technologies like TrueMed’s instant AI scanning, which can quickly verify packaging integrity and detect counterfeits on the spot. This proactive approach ensures that your products consistently meet quality standards and helps you identify counterfeit versions before they reach consumers.

4. Absence of Authentication Features

Many pharmaceutical companies have implemented authentication features such as QR codes, RFID tags, or unique serialization to help patients and healthcare providers verify the authenticity of their medications. Counterfeit versions of your product may lack these critical features, or display fake codes that don’t match your database.

How to Protect Your Brand: Increase the frequency of manual checks and spot audits at different points in your distribution chain. Regularly test samples of your products in the field, focusing on packaging consistency, labeling accuracy, and overall quality. Implement a simple checklist for distributors and pharmacists to follow, ensuring that key features like lot numbers, expiration dates, and packaging integrity are routinely verified. This hands-on, frequent testing approach allows you to catch potential counterfeit issues early and assess the ongoing effectiveness of your anti-counterfeiting measures without relying on complex technologies.

5. Suspicious Distribution Channels

Counterfeit pharmaceuticals often enter the market through unregulated or unauthorized distribution channels, including online pharmacies, social media marketplaces, or third-party distributors. If you see your product being sold by unfamiliar or unauthorized sellers, it’s likely that counterfeit drugs are part of the supply chain. This poses a significant risk not only to your business but also to patients relying on the authenticity of their treatment.

How to Protect Your Brand: Work closely with authorized distributors and set up agreements that restrict the sale of your pharmaceuticals to licensed channels. Use supply chain monitoring technologies to track the movement of your products from manufacturing to the end-user. Partner with regulatory bodies to target and remove counterfeit drugs from unauthorized markets.

Proactive Measures to Safeguard Your Pharmaceutical Products

Protecting your pharmaceutical brand from counterfeiting is a complex challenge, but there are several proactive steps you can take to reduce the risks:

• Implement Track-and-Trace Systems: Utilize serialization and digital tracking tools to monitor the movement of your products throughout the supply chain. This makes it easier to detect and remove counterfeit drugs before they reach patients.

• Collaborate with Regulatory Agencies: Work alongside the FDA, WHO, and other regulatory bodies to identify and remove counterfeit versions of your drugs from the market. To make the work effective and fast, enable digital tools to help with the authentication. Regulatory collaboration can help speed up the investigation and prosecution of counterfeiters.

• Monitor Online Pharmacies: Regularly scan online pharmacies and e-commerce platforms for unauthorized listings of your pharmaceuticals. Reporting these listings to the relevant authorities can prevent counterfeit drugs from reaching consumers.

• Educate Healthcare Providers: Enable pharmacists, doctors, and other healthcare professionals to recognize counterfeit drugs and report any suspicions to your company. This can be done with the latest digital authentication tools while the user does not need to know your secret composition. The quicker counterfeit drugs are identified, the sooner they can be removed from circulation.

• Customer Awareness Campaigns: Educate your customers about the risks of counterfeit drugs and how they can verify the authenticity of your products. This can be done through direct communication, patient education materials, or new digital platforms.

New digital tools for product protection are rapidly changing the way product protection is understood today. They require no additions to the packaging or changes in the factory, offering scalability to any user group across the globe. These tools are quickly emerging in the market and represent a shift in how awareness is raised and users are alerted and protected.

Pharmaceutical counterfeiting isn’t just a financial threat—it’s a matter of patient safety. By taking these steps and staying vigilant, your company can help reduce the risks of counterfeit drugs entering the supply chain, protect your brand, and, most importantly, safeguard the health of those who rely on your medications.

[Helsinki, 29OCT2024] – TrueMed, a leading provider of anti-counterfeiting technology solutions, is proud to announce its new partnership with a Top 10 global pharmaceutical company to bolster the integrity of its medications. This strategic collaboration will harness TrueMed’s cutting-edge AI technology to protect patients from the growing threat of counterfeit and illicit medicines, while also enhancing the pharmaceutical company’s field authentication and forensic capabilities. 

As counterfeit pharmaceutical volumes rise, and security professionals face increasing challenges in authenticating diverse types of packaging across various field environments, this partnership addresses critical needs. By leveraging TrueMed’s AI-powered platform, the pharmaceutical company significantly reduces reaction times during investigations, improves authentication accuracy in the field, and gathers critical forensic intelligence to support enforcement actions. 

TrueMed’s AI technology uses mobile phone cameras, machine learning, and data analytics to quickly analyze packaging, identifying counterfeit drugs and verifying authenticity in seconds. 

Jyrki Berg, CEO of TrueMed, remarks, “This partnership brings real change. By applying our forensic capabilities, we’re improving how counterfeit drug analysis is done, helping to make the pharmaceutical supply chain safer and more dependable.” 

For more information about TrueMed’s advanced AI-counterfeit detection solutions, please visit www.truemedinc.com. 

TrueMed is a leading provider of anti-counterfeiting technology solutions. The company’s AI-enabled platform uses cutting-edge technology to analyze and identify potential illicit products, allowing companies to quickly and efficiently protect their brands and their customers. 

For more information, please visit truemedinc.com. 
Contact: Tuomas Kannas, TrueMed, tuomas.kannas@truemedinc.com 

Counterfeit goods have become a significant issue, affecting industries from luxury fashion to electronics and everyday household products. Counterfeit items not only undermine brand integrity but also pose serious safety risks for consumers. With the rise in counterfeit goods, businesses and regulatory agencies have developed advanced methods to detect and combat these fakes. Over the years, new tools and technologies have been introduced, enhancing the ability to identify counterfeit products more efficiently. Here are the main forms of counterfeit detection that are employed for consumer goods: 

Holograms and Watermarks 

Holograms and watermarks are some of the most widely used methods to verify the authenticity of consumer goods, especially for high-value items such as luxury products, electronics, and pharmaceuticals. 

• Holograms often contain multi-dimensional images that change depending on the angle of view, providing a simple way to identify counterfeit products. 
• Watermarks are typically embedded into materials such as paper or fabric and are visible only under certain lighting or through specialized equipment. 
• Inks that typically are being visible or invisible. 

Pros: 

• • Effective for identifying secure markings on packaging. 
  • Provides clarity and strong communication. 

Cons: 

• • Increases costs. 
  • Limited to experts who can distinguish between real and fake holograms, as well as watermarks. 

Radio-Frequency Identification (RFID) 

RFID technology is one of the more advanced forms of counterfeit detection, frequently used in logistics and inventory management. RFID tags contain digital data that can be read by an RFID scanner, providing real-time tracking information for a product. 

This technology is particularly useful for large shipments and valuable items like electronics, automotive parts, and fashion goods, where each item can be traced through the supply chain from manufacturer to retailer.  

Pros: 

• • Hard to counterfeit when implemented properly. 
  • Commonly used for bulk product shipments. 

Cons: 

• • Can be costly when applied to individual products. 

Chemical and Physical Analysis

For certain products, especially pharmaceuticals, food, and high-value goods, chemical or physical analysis can be used to detect counterfeit versions. 

• Chemical tests can identify discrepancies in product composition that would indicate a counterfeit. 
• Physical analysis often involves examining materials, weight, color, and other factors to spot inconsistencies. 

This method is particularly useful for detecting counterfeit medicines, perfumes, and cosmetics where product ingredients or materials might be inferior or harmful. However, this is a time intensive and expensive process to implement.  

Pros: 

• • Chemical testing is highly accurate. 

Cons: 

• • Field labs are costly and difficult to scale. 
  • Shipping samples to forensic labs faces challenges due to country regulations, often leading to delays. 

Tamper-Evident Packaging

Tamper-evident packaging is designed to make any unauthorized access or tampering with a product immediately noticeable. This packaging often includes: 

• Seals that break if the product is opened. 
• Shrink-wraps that are difficult to replicate or replace. 

Once broken, tamper-evident features make it clear to the consumer that the product may have been compromised, prompting further checks for authenticity. 

Pros: 

• • Easy for users to see and understand. 

Cons: 

• • Increases packaging costs, as typically two or more seals are required.

UV and Infrared Markers

Specialized inks and markers, visible only under ultraviolet (UV) or infrared (IR) light, are often used to mark genuine products. These hidden markers provide an extra layer of security for brands looking to safeguard against counterfeiting. 

While visible branding elements like logos can be copied by counterfeiters, UV and IR markers are typically harder to replicate. Inspectors use UV or infrared light to reveal these hidden markers during authenticity checks. 

Pros: 

• • Appears professional and is generally challenging to replicate. 

Cons: 

• • Requires specialized devices for detection in the field, which limits scalability and increases costs.

Artificial Intelligence (AI) and Machine Learning

Artificial intelligence (AI) and machine learning are becoming the fastest-growing tools in the fight against counterfeiting. Unlike traditional methods, which may involve longer wait periods for testing and analysis, AI can offer real-time counterfeit detection with speed and precision. 

• AI-powered image recognition can scan and compare a product’s appearance to a database of authentic goods, spotting even the smallest inconsistencies that human eyes might miss. 
• Machine learning algorithms are constantly improving, allowing them to stay ahead of counterfeiters who are evolving their tactics. 

The primary advantage of AI is its ability to continuously learn from new counterfeit patterns, offering scalability and faster response times. As AI evolves, it provides businesses with a quicker, more dynamic solution, reducing the time and cost typically associated with traditional detection methods. This speed and adaptability make AI the most promising tool in the ongoing fight against counterfeit consumer goods. 

Important Note: When companies must inform the public about verifying a product’s authenticity, it often leads to unintended consequences. What many don’t realize is that this guidance also helps counterfeiters improve their fake products. While the intent behind sharing this information is good, it can quickly backfire. AI-powered digital tools now offer a solution by accurately detecting counterfeits without disclosing the verification process to the user. 

Pros: 

• • Highly accurate in detecting counterfeits. 
  • Capable of instantly identifying new counterfeit products without specalized equipment. 

Cons: 

• • Slow market adoption for large-scale implementation of new technologies. 

As counterfeit threats continue to grow, the need for advanced, multi-layered security strategies has never been more urgent. From traditional methods like holograms and watermarks to cutting-edge technologies like AI and machine learning, businesses have a diverse array of tools to protect their products and consumers. While each method presents unique advantages and challenges, the future of product and packaging security is undeniably digital. By leveraging these emerging technologies, brands can stay ahead of counterfeiters, safeguard their integrity, and provide consumers with the confidence they deserve. 

The threat of counterfeiting looms large, especially for industries such as healthcare, pharmaceuticals, and medical devices. At TrueMed, we’re deeply committed to helping our clients stay ahead of this issue by identifying early warning signs of counterfeit products entering the market. One of the earliest and most reliable indicators? Product diversions.

What is Product Diversion?

Product diversion occurs when authentic products are sold through unauthorized distribution channels or in regions not intended by the brand owner. Although the goods themselves are genuine, their path to market is unapproved, which can jeopardize the brand’s reputation. This lack of oversight not only undermines the company’s control over its distribution network but also opens the door to potential risks, such as diminished product quality and increased vulnerability to counterfeiting.

There are several ways product diversion can occur:

• Overproduction by manufacturers: A contract manufacturer may produce more units than ordered, then siphon the excess into unauthorized markets.

• Distributor surplus sales: A distributor may purchase more products than necessary and sell off the surplus through unauthorized or grey market channels.

• Distributor targets for additional profit: due to different pricing per different markets, diversion may bring huge additional profits for the distributors.

While diverted goods are real, the lack of control and oversight exposes both brands and consumers to the greater threat of counterfeit products entering the same channels.

Why Product Diversion Matters

At first glance, diversion may not seem like a critical issue—they involve real, authentic products, after all. However, diversions often serve as the earliest warning signs of a much larger problem: counterfeiting.

Product diversion weakens a brand’s control over its supply chain, opening the door for counterfeiters to step in. They see unauthorized distribution channels as an opportunity to produce and sell fake versions of the product, often making even larger profits by cutting corners on quality and safety.

This shift from selling real diverted products to counterfeit ones is a troubling trend that we’ve seen repeatedly with our clients. Unauthorized markets and channels become a fertile ground for counterfeit products, and once the criminals see success with diverted goods, they move quickly to replace them with fakes.

The Domino Effect: Diversion Leading to Counterfeiting

The logic for counterfeiters is straightforward: once they see that diverted, real products can sell in unauthorized channels, they begin to calculate how much more they can earn by manufacturing and distributing fake versions instead. This shift often occurs rapidly, with fake products entering the market shortly after an increase in diversion.

This is more than a financial problem—it can pose significant risks to consumers’ health, particularly in industries like pharmaceuticals, where counterfeit products can be deadly. In fact, product diversion often creates confusion in the supply chain, and when fake goods are introduced, they erode consumer trust and loyalty (Packaging Europe).

How TrueMed Helps Identify the Early Signs

At TrueMed, we use cutting-edge technology to help our clients detect product diversions before counterfeiters can infiltrate the market. By monitoring product flows and unauthorized sales channels, we help brands take proactive steps to secure their supply chains. Our clients have consistently reported that noticing an uptick in unauthorized sales is often followed by the appearance of counterfeit products in the same markets.

By identifying and addressing diversion early, companies can protect their brand, revenue, and, most importantly, the safety of their consumers.

The Bottom Line

If you’re seeing signs of diversion in your distribution network, consider it an early warning signal. Diversion doesn’t just undermine your control—it opens the floodgates for counterfeiters. At TrueMed, we work with brands to identify diversion early and prevent the escalation to counterfeit products.

If you’re ready to safeguard your products and stay ahead of potential diversion and counterfeiting threats, reach out to TrueMed today.

The global market for counterfeit pharmaceuticals is booming, with lifestyle drugs and controlled substances at the forefront. These high-demand medications, which often fetch premium prices, have become prime targets for counterfeiters. The consequences of these fake medications range from ineffective treatment to life-threatening overdose risks, highlighting a growing health crisis.

Lifestyle Drugs: A Target for Counterfeiters

Lifestyle medications, such as weight-loss drugs and erectile dysfunction treatments, are increasingly counterfeited. Drugs like Ozempic, Mounjaro® and Zepbound® used for diabetes management and weight loss, and Viagra, used for erectile dysfunction, are in high demand but can be expensive. This demand has spurred a flood of counterfeit products that are sold through rogue online pharmacies and social media platforms (Pharmaceutical Technology) (UConn Today).

These counterfeit versions often contain harmful additives, incorrect dosages, or lack the necessary active ingredients to provide the expected therapeutic effect. In some cases, counterfeit medications have been found to contain dangerous chemicals like arsenic and rat poison (Pharmaceutical Technology).

Controlled Substances: A Deadly Trade

The counterfeiting of controlled substances is particularly lethal. Fentanyl-laced pills, disguised as legitimate medications like Oxycodone or Xanax, are a major contributor to the ongoing opioid overdose crisis. Fentanyl, a synthetic opioid that is significantly more potent than heroin, is often added to these counterfeit pills in untraceable doses, making them deadly (US Pharmacist).

In 2022 alone, more than 105,000 people in the United States died from drug overdoses, with a large portion of those deaths linked to counterfeit fentanyl-laced pills (US Pharmacist). These pills are sold on the black market and through illegal online pharmacies, posing a major public health risk.

The Role of Online Pharmacies and Social Media

Illegal online pharmacies and social media platforms are key distribution channels for counterfeit drugs. Many rogue websites operate with little to no regulation, making it easy for consumers to purchase counterfeit drugs without prescriptions. The National Association of Boards of Pharmacy reported that 96% of online pharmacies were not in compliance with U.S. federal laws, and many did not reveal their physical locations (UConn Today).

Social media platforms also facilitate the sale of counterfeit drugs, targeting younger audiences and allowing counterfeiters to operate anonymously (Partnership for Safe Medicines). This ease of access has contributed to the rise in overdose deaths, especially in vulnerable populations.

What can we do?

The rise of counterfeit lifestyle drugs and controlled substances poses a grave threat to public health. With counterfeiters targeting high-demand medications like weight-loss treatments, erectile dysfunction pills, and opioids, the risks are escalating rapidly. This is particularly concerning as counterfeiters exploit weak regulatory oversight, online pharmacies, and social media platforms

To combat this crisis, technology plays a vital role in securing the pharmaceutical supply chain. Advanced track-and-trace systems, already being implemented globally, allow for greater transparency by ensuring that every drug can be monitored from production to point of sale. While this helps lower the risk of counterfeit products infiltrating legitimate supply chains, it doesn’t fully resolve the issue. We must push for a system that can verify the authenticity of a product, even when the serial number and lot/expiration dates appear correct, but the product is still counterfeit.

Innovations like TrueMed offer powerful tools to investigators and counterfeit laboratories, helping them authenticate medications and verify the legitimacy of drugs across the supply chain without being an security expert. By using advanced scanning technology, TrueMed enables investigators to authenticate counterfeit drugs, ensuring greater protection for consumers and enhancing the security of pharmaceutical products

Despite these advances, public awareness and the adoption of these technologies are key to effectively combat counterfeit drugs. Increased regulatory action combined with modern digital tools will provide the pharmaceutical industry and law enforcement agencies with a robust defense, but it’s up to consumers and regulators alike to remain vigilant.

References:

1. Pharmaceutical Technology. “Drug counterfeiting is rising rapidly in emerging markets.” Published February 2024. (Pharmaceutical Technology

)tps://www.pharmaceutical-technology.com/analyst-comment/drug-counterfeiting-is-rising-rapidly-in-emergin (UConn Today)/).

1. UConn Today. “Dangerous Counterfeit Drugs are Putting Millions at Risk.” Published Septe (US Pharmacist). Link.

1. US Phar (Partnership for Safe Medicines) increase in Counterfeit Pills, Drug Overdoses.” Published September 2023. Link.

1. Partnership for Safe Medicines. “The threat and enforcement challenges of counterfeit medicines.” Published February 2024. Link.

TrueMed is proud to announce the latest innovation in our ongoing mission to enhance and expand the capabilities of the TrueMed Digital Forensic Lab. We are excited to introduce the integration of lab scanners, such as a tabletop scanners,into our digital lab process, making it easier than ever to authenticate, analyze, document, and instantly report products with unmatched accuracy and efficiency.

Seamless Integration for Enhanced Precision

With this new capability, you can now directly use scanned images from your lab scanner within the TrueMed Digital Forensic Lab. This integration means that in addition to using our mobile app, you can also harness the power of your existing scanning technology to upload high-resolution images directly into the lab’s digital ecosystem. This advancement offers a host of benefits, ensuring that your analysis is more detailed and precise than ever before.

Higher Resolution for In-Depth Analysis

One of the key advantages of using a scanner is the ability to capture images at a higher resolution. This level of detail allows you to see even the smallest imperfections and irregularities, such as rasterization, which can be crucial in identifying counterfeit or tampered products. The clarity provided by scanned images means that nothing goes unnoticed, giving you the confidence that your analysis is comprehensive.

Comprehensive Surface Analysis

When using a scanner, you can also take advantage of the ability to flatten boxes or packaging, allowing for a complete analysis of all surfaces simultaneously. This is particularly beneficial for larger boxes or complex packaging, where traditional mobile scanning might struggle to capture every detail. With the entire package laid flat, you can inspect every inch in one go, ensuring that no aspect of the product is overlooked.

Efficiency and Speed in Your Workflow

Incorporating scanners into your TrueMed Digital Forensic Lab workflow is not just about enhancing accuracy—it’s also about improving speed. By integrating this new functionality, you can now streamline your existing scanning process, making it faster and more efficient. The transition from scanning to analysis is seamless, reducing the time spent on manual uploads and allowing you to focus more on what matters—ensuring the integrity of the products you handle.

A Solution for Challenging Environments

In regions where mobile access is limited or unreliable, scanners provide a vital alternative. The ability to use scanners instead of mobile devices means that the TrueMed Digital Forensic Lab remains accessible and functional, even in areas with poor connectivity. This flexibility ensures that you can maintain high standards of product verification and analysis, regardless of your location or technological constraints. Naturally this also helps organisations that do have tabletop scanners integrated into their existing visual inspection processes.

Expanding the TrueMed Digital Lab’s Capabilities

The integration of scanners into the TrueMed Digital Lab is just one of the many ways we are extending the modalities of our platform. Our commitment to innovation drives us to continually seek out new methods and technologies that enhance your ability to protect your products and consumers. As we continue to evolve, you can expect even more groundbreaking features and tools that will further solidify TrueMed as the leader in digital product verification and analysis.

This latest advancement is a testament to TrueMed’s dedication to providing cutting-edge solutions that meet the evolving needs of our clients. By incorporating scanners into the digital lab process, we’re not just adding another tool to your arsenal—we’re empowering you with greater accuracy, efficiency, and flexibility in your fight against counterfeit and illicit products.

While much focus is placed on the supply chain, from production to the point of sale, there’s an often-overlooked opportunity: checking product returns for counterfeits. This simple yet effective measure can not only safeguard patients but also protect a company’s bottom line. However, despite its significance, many pharmaceutical companies remain unaware or have only scratched the surface of this untapped potential. 

The issue of counterfeit medicines is not new, but the alarming rates at which they infiltrate markets globally demand immediate attention. In Latin America, for instance, some companies have reported finding as much as 80% of returned products to be counterfeit. These figures highlight a critical blind spot in the fight against counterfeits—one that is currently underutilized by most pharma companies. 

Why Checking Returns Matters 

Uncovering the Extent of the Problem: Product returns are a goldmine of information for pharmaceutical companies. By systematically checking returns for authenticity, companies can gain critical insights into the prevalence and patterns of counterfeiting in various markets. This data is invaluable, not only for internal use but also for reporting to authorities, thereby helping to combat the broader issue of counterfeit drugs. 

Protecting Your Bottom Line: Counterfeit products represent a direct loss to your company. Each time a fake drug is sold in place of the genuine article, it’s not just your reputation that suffers; you are, in effect, paying criminals from your top line. This is a loss that can and should be mitigated by a robust system of return checks. Even worse, when the company is receiving returned products and re-imbursing them back on counterfeit items. This is a direct loss from the top line. 

Safeguarding Patient Health: Perhaps most importantly, failure to check product returns for counterfeits directly endangers patients. Counterfeit drugs often contain incorrect dosages or harmful ingredients, posing serious health risks. By identifying and addressing counterfeits through return checks, companies can play a vital role in ensuring patient safety, direct investigations and related activities and collect new addressable data from each market 

Despite the clear benefits, many pharmaceutical companies have yet to implement comprehensive return checks. Some have experimented with such measures in regions like Latin America, but the practice is far from widespread. This presents an enormous untapped opportunity for companies willing to take proactive steps to secure their supply chains and protect their brands. 

Moreover, companies that lead the charge in this area will likely find themselves better positioned in the market. As regulators and consumers alike become more aware of the counterfeit problem, those companies that can demonstrate a commitment to safety and quality will have a competitive edge. 

Checking product returns for counterfeits is not just a defensive measure—it’s a strategic advantage. It’s an opportunity for pharmaceutical companies to gain insights, protect their revenue, and, understand the market. In a world where the threat of counterfeit medicines continues to grow, this is one opportunity that should not be overlooked. 

The Economic Impact of Counterfeit Healthcare Products

Counterfeit healthcare products are a growing concern worldwide, affecting not only patient safety but also having significant economic repercussions. The proliferation of fake medications and medical devices undermines public health, drains economic resources, and imposes substantial costs on the healthcare industry. The importance of initiatives like TrueMed in mitigating these effects has transitioned from a luxury to a necessity.

The Scope of the Problem

The global trade in counterfeit pharmaceuticals is estimated to be worth between $200 billion and $431 billion annually, according to a report by the World Health Organization (WHO). The WHO reports that up tp 10% of medicines available globally could be counterfeit. This alarming figure represents a significant portion of the total pharmaceutical market, indicating the widespread nature of the problem. Counterfeit products can range from fake versions of brand-name drugs to substandard generic drugs, affecting a wide array of therapeutic categories and posing a substantial threat to public health.

Direct Economic Costs

Loss of Revenue for Legitimate Manufacturers: Counterfeit products siphon off revenue from legitimate manufacturers, leading to substantial financial losses. Pharmaceutical companies invest heavily in research and development (R&D) to bring new drugs to market. The presence of counterfeit products erodes their market share and profitability, which in turn affects their ability to fund future R&D projects. This loss of revenue can hinder the advancement of new and innovative treatments, ultimately affecting patient care and medical progress.

Increased Healthcare Costs: The presence of counterfeit drugs can lead to treatment failures, adverse reactions, and prolonged illnesses, resulting in additional medical expenses. According to the National Association of Boards of Pharmacy (NABP), counterfeit drugs contribute to an estimated $75 billion annual loss to the global economy due to increased healthcare costs and lost income from prolonged illness. Patients who unknowingly consume counterfeit drugs may experience worsened health conditions, leading to increased visits to healthcare facilities, additional diagnostic tests, and prolonged treatment regimens.

Costs to Regulatory and Enforcement Agencies: Government regulatory and enforcement agencies incur significant costs in their efforts to combat counterfeit healthcare products. These costs include monitoring and surveillance, investigation and enforcement actions, and public awareness campaigns. The resources allocated to these activities could otherwise be directed toward enhancing public health infrastructure and services.

Indirect Economic Costs

Impact on Employment: The economic burden extends to employment in the pharmaceutical industry. Legitimate manufacturers may face reduced sales and profits, leading to job losses and a decrease in investment in the workforce. Pharmaceutical companies may also be compelled to downsize or relocate operations to mitigate financial losses, resulting in further job displacements and economic instability in affected regions.

Strain on Healthcare Systems: Counterfeit products often lead to increased hospital admissions and longer hospital stays, putting a strain on healthcare systems. This additional burden diverts resources from other critical areas of healthcare, exacerbating the economic impact. For example, the need to treat complications arising from counterfeit drug use may lead to the postponement or cancellation of elective surgeries, creating a backlog of medical procedures and prolonging patient suffering.

Loss of Public Trust: The proliferation of counterfeit healthcare products undermines public trust in the healthcare system. Patients who fall victim to counterfeit drugs may lose confidence in their healthcare providers and the medications they are prescribed. This loss of trust can have far-reaching consequences, including reduced patient adherence to prescribed treatments and a general decline in public health outcomes. In all cases, patient or consumer is the ultimate loser and is suffering the consequences.

Global Trade and Economic Stability

Counterfeit healthcare products also disrupt global trade and economic stability. The infiltration of fake products into legitimate supply chains can damage the reputation of affected countries, reduce foreign investment, and harm international trade relations. The Organization for Economic Co-operation and Development (OECD) estimates that counterfeit goods, including pharmaceuticals, account for 3.3% of global trade. The economic ramifications of counterfeit products extend beyond the healthcare sector, affecting a wide range of industries and contributing to global economic instability.

The Role of TrueMed

TrueMed plays a crucial role in combating the economic impact of counterfeit healthcare products. By leveraging the Digital Forensic Lab to verify the authenticity of medications, TrueMed helps protect legitimate manufacturers’ revenues and ensures patients receive safe and effective treatments. TrueMed uses AI-driven, cutting-edge solutions that secure the pharmaceutical supply chain and prevent counterfeit products from reaching consumers without requiring any modifications to manufacturing.

TrueMed’s efforts enhance the global economy by reducing counterfeit products and their associated costs. By securing the pharmaceutical supply chain, TrueMed helps maintain public trust in healthcare systems and supports the industry’s economic stability. Prioritizing the fight against counterfeits safeguards public health and protects economic stability. TrueMed’s innovative solutions ensure patients receive genuine, safe treatments while bolstering the resilience of the pharmaceutical sector.

References

1. World Health Organization (WHO). (2017). “A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products.” WHO Report.
2. National Association of Boards of Pharmacy (NABP). (2020). “Counterfeit Drugs: Real Risks, Real Solutions.” NABP Report.
3. Organization for Economic Co-operation and Development (OECD). (2019). “Trends in Trade in Counterfeit and Pirated Goods.” OECD Report.

[Helsinki, 23MAY2024] TrueMed, the leading provider of anti-counterfeiting technology solutions for pharmaceuticals, announces its selection by a top 10 global pharmaceutical with medications spanning across oncology, cardiovascular, respiratory, vaccines, and more.

The partnership comes at a critical time, as counterfeit medications become increasingly sophisticated, posing a grave risk to patient safety worldwide. TrueMed’s advanced AI technology is uniquely capable of identifying the subtle indicators of counterfeit products, providing a level of detection precision that far exceeds traditional methods.

A key innovation of this collaboration is the decentralization of the authentication process. TrueMed’s technology will be deployed directly to frontline staff, empowering local investigators with the tools to quickly and accurately analyze suspicious samples. This approach not only expedites the investigative process but also significantly increases its efficiency and volume, ensuring a more robust defense against counterfeit medications.

Moreover, the adoption of TrueMed’s AI solutions by the leading pharmaceutical is expected to reduce the reliance on physical security features in packaging. This shift promises to lower costs and simplify packaging processes, aligning with environmental sustainability goals without compromising the integrity of the medications.

“This partnership isn’t just about technology; it’s about taking a stand for the safety of patients everywhere. The counterfeiters are getting smarter, using advanced methods to deceive us. That’s why it’s critical we outsmart them at every turn. Our AI isn’t just a collection of algorithms – it’s a powerful ally for the people on the ground, helping them catch what the naked eye can easily miss. Together, we’re making a real difference in the fight against fake meds.”, commented Jyrki Berg, CEO TrueMed.

For additional insights into TrueMed’s advanced AI-based anti-counterfeiting solutions, please visit www.truemedinc.com.

About TrueMed.

TrueMed is a leading provider of anti-counterfeiting technology solutions. The company’s AI-enabled platform uses cutting-edge technology to analyze and identify potential counterfeit products, allowing companies to quickly and efficiently protect their brands and their customers.

For more information, please visit truemedinc.com.
Contact: Tuomas Kannas, TrueMed, tuomas.kannas@truemedinc.com

In the complex ecosystem of healthcare, where the stakes involve life itself, the emergence of counterfeit pharmaceuticals as a global threat raises a critical question: who is ultimately responsible for keeping patients safe? While the integrity of pharmaceuticals is a cornerstone of patient safety, the reach of counterfeit medications across the globe challenges us to re-evaluate the roles and responsibilities within the healthcare supply chain.

The World Health Organization (WHO) has flagged counterfeit medications as a significant global issue, with estimates suggesting that up to 10% of medicines worldwide might be counterfeit, skyrocketing to 30% in some regions. The risk posed by counterfeit pharmaceuticals ranges from ineffective treatments to life-threatening complications, making the detection and prevention of such products paramount.

One might argue that the pharmaceutical companies, with their resources and expertise, are best positioned to lead the charge against counterfeits. After all, ensuring the authenticity of their products from production to patient should be a fundamental operation. Innovative technologies such as AI offer promising solutions to trace and verify the legitimacy of drugs throughout the supply chain, potentially outsmarting counterfeiters at their own game. But is the burden theirs alone?

Consider a scenario where counterfeit goods are shipped from ASIA to the US. The question arises: Who should be responsible for this? Some argue that manufacturers should verify their products’ authenticity, but this view doesn’t fully account for the role of distributors, who often profit by bringing in these fakes. For instance, if a distributor unknowingly imports counterfeit medications, they still make a profit, while the costs of dealing with these fakes could fall on the government or the original manufacturers.

Regulatory bodies and governments play a crucial role in establishing and enforcing standards and regulations to safeguard public health. Their authority allows them to implement measures that can significantly deter counterfeiters. However, regulations vary significantly across borders, and the effectiveness of enforcement can be inconsistent. In regions where oversight is weaker, counterfeit drugs proliferate, posing risks not just locally but also to travelers unaware of the dangers.

Healthcare providers are on the frontline, directly interacting with patients and medications. Their position enables them to be vigilant observers and educators, potentially identifying and warning against counterfeit medications. Yet, without the tools to verify authenticity or the knowledge of the prevalence of counterfeits, their ability to protect patients is limited.

Patients themselves, often the most vulnerable and least equipped to identify counterfeit medications, are thrust into a situation where they must trust the integrity of the drugs they consume. Educating patients on the risks of counterfeit drugs and empowering them to ask questions about the source of their medications can be a vital step in patient safety. But again, the question arises – should the onus be on them?

The answer to who bears the ultimate responsibility for protecting patients from counterfeit pharmaceuticals is not straightforward. It’s a shared responsibility, requiring a multifaceted approach that involves pharmaceutical companies, regulatory bodies, healthcare providers, even distributors and finally patients themselves. Each stakeholder in the healthcare ecosystem must play their part, with pharmaceutical companies innovating to stay ahead of counterfeiters, governments enforcing strict regulations, healthcare providers educating and being vigilant, and patients being informed and cautious.

Safeguarding against counterfeit pharmaceuticals is a collective battle, one that demands collaboration, innovation, and vigilance from all corners of the healthcare system. Only through a united front can we hope to protect patients from the dangers of counterfeit medications, ensuring the safety and integrity of the pharmaceuticals upon which so many rely.